Hyam Levitsky - President of R&D at Century Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Hyam Levitsky since 09 Aug 2025

Reported holdings for Hyam Levitsky in Century Therapeutics, Inc.

Form 4 holding President of R&D

Century Therapeutics, Inc.

Security class
Common Stock
Shares / value
536,544
Estimated value
$2,757,622
Report date
07 Mar 2024
Price
$5.14
Ownership
By Irrevocable Spousal Trust for Rhonda L. Zuckerman
Form 4 holding President of R&D

Century Therapeutics, Inc.

Security class
Common Stock
Shares / value
24,000
Estimated value
$123,350
Report date
07 Mar 2024
Price
$5.14
Ownership
Direct
Form 4 holding President of R&D

Century Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
146,000
Estimated value
Report date
07 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Hyam Levitsky in Century Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .